## CCEP: Coca-Cola Europacific Partners  - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 1.42 indicates fundamental undervaluation. Quality metrics strong (ROE 18%). Caution: declining volume (54% of avg), momentum weakening (-1.9% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($89.29)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Coca-Cola Europacific Partners Announces Total Voting Rights Update**
- Source: TipRanks | 20251202T051237 | Neutral | Relevance: 98%
-  Coca-Cola Europacific Partners reported that as of November 30, 2025, it has 449,993,052 ordinary shares in issue, each with one vote and no treasury shares. This total voting rights figure is important for shareholders to meet notification obligations under the FCAâ€™s Disclosure Guidance and Transparency Rules. The company operates in the beverage industry, producing and distributing Coca-Cola branded products.

**2. Coca-Cola Europacific Partners discloses management share acquisitions and voting rights**
- Source: Investing.com | 20251202T051237 | Neutral | Relevance: 97%
-  Coca-Cola Europacific Partners (NASDAQ:CCEP) has reported that several executives acquired ordinary shares through the UK Share Plan and UK Shareshop on November 19, 2025. This includes Edward Walker, Clare Wardle, Peter Brickley, Stephen Lusk, Leendert den Hollander, and Stephen Moorhouse, with shares acquired at varying prices including some at no cost. The company also disclosed its total number of voting rights as of November 30, 2025, which stands at 449,993,052.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 16.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Invesco Ltd.: 3.5% (+31.6%)
- Blackrock Inc.: 3.4% (-1.3%)
- Vanguard Group Inc: 2.4% (+2.6%)
- Goldman Sachs Group : 1.5% (+6.9%)
- Boston Partners: 1.4% (+2.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.42 suggests fair value with growth premium. Forward P/E 20.8x stretched relative to 9% growth. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $40.6B |
| Beta | 0.38 |
| 52W Range | $73.40 - $100.67 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.42 |
| Forward P/E | 20.8 |
| Current P/E | 22.6 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.7% to 0.8% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.2pp (needs >4.0% for momentum thesis). MRS_5 at 0.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58. Volume at 54% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.81% (CS: 68) | Neutral |
| RSI_14 | 58.5 | Neutral |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.027x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $92.45
- **Stop Loss:** $89.29 (3.4% risk)
- **Target:** $98.77 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 316
- **Position Value:** $29,214.20
- **Portfolio %:** 29.21%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-17 (Est: $0.00)

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*